Rasha SLIKA has been recruited as a PhD fellow in the team of Frederic Charbonnier. She works on
WP 4: Screening of potential therapeutic molecules and more especially on the WP 4.2 In vivo Efficacy, for studying: Impact of HDAC6 Inhibition on Muscle Atrophy in Spinal Muscular Atrophy
